These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3590066)

  • 1. [A searchable data bank on the Minitel system for iatrogenic pathology and drug interactions designed for practitioners].
    Escousse A; Bianchetti D; Sgro C; Parfait S; Perceau JP
    Therapie; 1987; 42(1):57. PubMed ID: 3590066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages of a microcomputer system in researching duplicated reports].
    Biour M; Wagniart F; Jablonka J; Hamel JD; Weissenburger J; Cheymol G
    Therapie; 1986; 41(5):383-4. PubMed ID: 3810530
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of adverse drug reactions by computerized drug interaction screening.
    Davidson KW; Kahn A; Price RD
    J Fam Pract; 1987 Oct; 25(4):371-5. PubMed ID: 3655673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ensuring safe medication in the physician's office].
    Niebling W
    MMW Fortschr Med; 2006 May; 148(19):44-5. PubMed ID: 16736706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
    Hamel JD; Biour M; Cheymol G
    Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug interactions in an intensive care unit].
    Nielsen EW; Dybwik K
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2907-8. PubMed ID: 15550963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activities of a regional drug monitoring center. What to evaluate, how and for what purpose].
    Péré JC; Haramburu F; Bégaud B; Barat C; Laborde B; Albin H
    Therapie; 1987; 42(4):351-8. PubMed ID: 3686468
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early identification of the tolerance profile of agents under clinical investigation].
    Palminteri R; Sarazin E; Narbonne G
    Therapie; 1987; 42(4):343-6. PubMed ID: 3317981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of French drug data banks].
    Séroussi B; Gérondeau N; Morice V; Boisvieux JF
    Therapie; 1997; 52(3):207-12. PubMed ID: 9366104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction microcomputer software evaluation: Drug Therapy Screening System (DTSS).
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Aug; 25(8):738-41, 744. PubMed ID: 10170582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug monitoring].
    Royer RJ
    Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
    [No Abstract]   [Full Text] [Related]  

  • 14. Sales reps: footsoldiers in drug company wars.
    Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medico-legal viewpoint and iatrogenic pathology].
    Guillaûmat L
    Annee Ther Clin Ophtalmol; 1982; 33():317-35. PubMed ID: 7186291
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoiding drug interactions.
    Generali J
    Am Fam Physician; 2000 Mar; 61(6):1628, 1630, 1637. PubMed ID: 10750872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Self-assessment by physicians concerning their management of drug risks. Information sources, risk evaluation, problems and recommendations for improvements].
    Kemmnitz W
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):509-12. PubMed ID: 9842698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulatory guidelines and drug safety].
    Flury W
    Ther Umsch; 1993 Jan; 50(1):49-51. PubMed ID: 8378867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of computer applications in institutional pharmacy--1975-1981.
    Burleson KW
    Am J Hosp Pharm; 1982 Jan; 39(1):53-70. PubMed ID: 7055149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Communication and transparency concerning risk-benefit analysis in public health: the example of medication].
    Lehner JP; Meyer F; Juillet Y
    Therapie; 2001; 56(4):335-9. PubMed ID: 11677849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.